That’s a fair comment....if that’s the last of their selling. The real test will be if they continue this steady offloading that began at the beginning of February and has seen them lightening the load by around 15m shares.
They know another rejection here will see a repeat of last years price collapse for which they have little appetite so some nice profit is there for the taking now. My guess is that while they don’t have “insider news” we haven’t seen the last of it and there’s been a policy shift where they are seeing opportunities present elsewhere possibly nox, rap, sva and others which have all seen ce marking or fda approvals of late etc etc with this being seen as becoming riskier the longer it remains in limbo awaiting another bsi judgement.
Me I’m still in for the ‘red or black’ short term gamble as that, unfortunately, is what it has boiled down to. Medium to long term it’s a much less riskier prospect imo.
OSL Price at posting:
16.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)